Annual SGA
$30.62 M
+$4.21 M+15.93%
December 31, 2023
Summary
- As of February 8, 2025, ALGS annual SGA is $30.62 million, with the most recent change of +$4.21 million (+15.93%) on December 31, 2023.
- During the last 3 years, ALGS annual SGA has risen by +$12.67 million (+70.62%).
- ALGS annual SGA is now at all-time high.
Performance
ALGS SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$4.63 M
-$1.75 M-27.45%
September 30, 2024
Summary
- As of February 8, 2025, ALGS quarterly SGA is $4.63 million, with the most recent change of -$1.75 million (-27.45%) on September 30, 2024.
- Over the past year, ALGS quarterly SGA has dropped by -$1.79 million (-27.96%).
- ALGS quarterly SGA is now -52.39% below its all-time high of $9.72 million, reached on December 31, 2021.
Performance
ALGS Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$2.06 B
-$76.95 M-3.88%
September 30, 2024
Summary
- As of February 8, 2025, ALGS TTM SGA is -$2.06 billion, with the most recent change of -$76.95 million (-3.88%) on September 30, 2024.
- Over the past year, ALGS TTM SGA has dropped by -$2.09 billion (-6831.49%).
- ALGS TTM SGA is now -3013.30% below its all-time high of -$66.20 million.
Performance
ALGS TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ALGS Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +15.9% | -28.0% | -6831.5% |
| 3 y3 years | +70.6% | -45.6% | -7340.4% |
| 5 y5 years | - | -45.6% | -7340.4% |
ALGS Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +15.9% | -52.4% | at low | -105.5% | at low |
| 5 y | 5-year | at high | +206.0% | -52.4% | +35.3% | -3013.3% | at low |
| alltime | all time | at high | +206.0% | -52.4% | +66.7% | -3013.3% | at low |
Aligos Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $4.63 M(-27.4%) | $24.09 M(-7.0%) |
| Jun 2024 | - | $6.38 M(-4.4%) | $25.91 M(-10.0%) |
| Mar 2024 | - | $6.67 M(+3.8%) | $28.78 M(-6.0%) |
| Dec 2023 | $30.62 M(+15.9%) | $6.42 M(-0.3%) | $30.62 M(-2.2%) |
| Sep 2023 | - | $6.44 M(-30.3%) | $31.31 M(+3.9%) |
| Jun 2023 | - | $9.25 M(+8.7%) | $30.13 M(+5.9%) |
| Mar 2023 | - | $8.51 M(+19.5%) | $28.46 M(+7.8%) |
| Dec 2022 | $26.41 M | $7.12 M(+35.3%) | $26.41 M(-9.0%) |
| Sep 2022 | - | $5.26 M(-30.5%) | $29.01 M(-4.0%) |
| Jun 2022 | - | $7.58 M(+17.4%) | $30.22 M(+3.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $6.45 M(-33.6%) | $29.20 M(+2.4%) |
| Dec 2021 | $28.53 M(+59.0%) | $9.72 M(+50.1%) | $28.53 M(+14.0%) |
| Sep 2021 | - | $6.47 M(-1.3%) | $25.02 M(+9.9%) |
| Jun 2021 | - | $6.56 M(+13.4%) | $22.77 M(+12.1%) |
| Mar 2021 | - | $5.78 M(-6.8%) | $20.31 M(+13.2%) |
| Dec 2020 | $17.94 M(+79.4%) | $6.21 M(+46.9%) | $17.94 M(+18.0%) |
| Sep 2020 | - | $4.22 M(+3.2%) | $15.20 M(+10.5%) |
| Jun 2020 | - | $4.09 M(+19.8%) | $13.75 M(+42.4%) |
| Mar 2020 | - | $3.42 M(-1.3%) | $9.66 M(+54.8%) |
| Dec 2019 | $10.01 M | $3.46 M(+24.8%) | $6.24 M(+124.8%) |
| Sep 2019 | - | $2.77 M | $2.77 M |
FAQ
- What is Aligos Therapeutics annual SGA?
- What is the all time high annual SGA for Aligos Therapeutics?
- What is Aligos Therapeutics annual SGA year-on-year change?
- What is Aligos Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Aligos Therapeutics?
- What is Aligos Therapeutics quarterly SGA year-on-year change?
- What is Aligos Therapeutics TTM SGA?
- What is the all time high TTM SGA for Aligos Therapeutics?
- What is Aligos Therapeutics TTM SGA year-on-year change?
What is Aligos Therapeutics annual SGA?
The current annual SGA of ALGS is $30.62 M
What is the all time high annual SGA for Aligos Therapeutics?
Aligos Therapeutics all-time high annual SGA is $30.62 M
What is Aligos Therapeutics annual SGA year-on-year change?
Over the past year, ALGS annual SGA has changed by +$4.21 M (+15.93%)
What is Aligos Therapeutics quarterly SGA?
The current quarterly SGA of ALGS is $4.63 M
What is the all time high quarterly SGA for Aligos Therapeutics?
Aligos Therapeutics all-time high quarterly SGA is $9.72 M
What is Aligos Therapeutics quarterly SGA year-on-year change?
Over the past year, ALGS quarterly SGA has changed by -$1.79 M (-27.96%)
What is Aligos Therapeutics TTM SGA?
The current TTM SGA of ALGS is -$2.06 B
What is the all time high TTM SGA for Aligos Therapeutics?
Aligos Therapeutics all-time high TTM SGA is -$66.20 M
What is Aligos Therapeutics TTM SGA year-on-year change?
Over the past year, ALGS TTM SGA has changed by -$2.09 B (-6831.49%)